[{"Assets_0_FY_USD":993151000.0,"CommonStockSharesOutstanding_0_FY_shares":90797087.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":101364000.0,"NetIncomeLoss_4_FY_USD":21111000.0,"NetIncomeLoss_1_FY_USD":18078000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":90235000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":90742000.0,"StockholdersEquity_0_FY_USD":480765000.0,"EarningsPerShareBasic_1_FY_USD":0.2,"EarningsPerShareBasic_4_FY_USD":0.23,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190208"}]